Andrew W. McFadden

858 total citations
18 papers, 641 citations indexed

About

Andrew W. McFadden is a scholar working on Molecular Biology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andrew W. McFadden has authored 18 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Hematology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andrew W. McFadden's work include PI3K/AKT/mTOR signaling in cancer (4 papers), Cell Adhesion Molecules Research (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Andrew W. McFadden is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (4 papers), Cell Adhesion Molecules Research (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Andrew W. McFadden collaborates with scholars based in United States, Canada and Germany. Andrew W. McFadden's co-authors include Ian J. Davis, Leslie V. Parise, Rajni Chibbar, Emina Torlakovic, Miķelis Bickis, Nael Shoman, Weiping Yuan, Jeremy M. Simon, Sam Wu and Yixiang Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Andrew W. McFadden

17 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew W. McFadden United States 12 360 202 151 106 79 18 641
Vanessa Cerisano Italy 11 396 1.1× 318 1.6× 183 1.2× 46 0.4× 163 2.1× 11 750
Fumihiro Kimura Japan 12 271 0.8× 82 0.4× 84 0.6× 66 0.6× 90 1.1× 39 628
Ulla Aspenblad Sweden 11 199 0.6× 114 0.6× 181 1.2× 92 0.9× 120 1.5× 13 510
Ana Teresa Amaral Spain 13 317 0.9× 244 1.2× 206 1.4× 34 0.3× 150 1.9× 20 633
Andreas Lux Germany 17 416 1.2× 373 1.8× 78 0.5× 31 0.3× 73 0.9× 26 907
Uwe Jerke Germany 13 232 0.6× 104 0.5× 112 0.7× 155 1.5× 222 2.8× 18 639
Abdo J. Najy United States 14 367 1.0× 111 0.5× 222 1.5× 98 0.9× 180 2.3× 23 618
Carlos Rı́us Spain 12 473 1.3× 148 0.7× 126 0.8× 75 0.7× 90 1.1× 19 755
Veronica R. Placencio United States 8 354 1.0× 212 1.0× 230 1.5× 37 0.3× 238 3.0× 13 666
Yingfu Liu China 14 297 0.8× 65 0.3× 167 1.1× 43 0.4× 131 1.7× 19 559

Countries citing papers authored by Andrew W. McFadden

Since Specialization
Citations

This map shows the geographic impact of Andrew W. McFadden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew W. McFadden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew W. McFadden more than expected).

Fields of papers citing papers by Andrew W. McFadden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew W. McFadden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew W. McFadden. The network helps show where Andrew W. McFadden may publish in the future.

Co-authorship network of co-authors of Andrew W. McFadden

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew W. McFadden. A scholar is included among the top collaborators of Andrew W. McFadden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew W. McFadden. Andrew W. McFadden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wali, Aminah, Kyle V. Butler, Yan Xiong, et al.. (2023). MS0621, a novel small-molecule modulator of Ewing sarcoma chromatin accessibility, interacts with an RNA-associated macromolecular complex and influences RNA splicing. Frontiers in Oncology. 13. 1099550–1099550. 3 indexed citations
2.
Shanle, Erin K., et al.. (2018). PBRM1 bromodomains variably influence nucleosome interactions and cellular function. Journal of Biological Chemistry. 293(35). 13592–13603. 23 indexed citations
3.
Pattenden, Samantha G., Jeremy M. Simon, Aminah Wali, et al.. (2016). High-throughput small molecule screen identifies inhibitors of aberrant chromatin accessibility. Proceedings of the National Academy of Sciences. 113(11). 3018–3023. 24 indexed citations
4.
Gomez, Nicholas C., Andrew W. McFadden, Billie M. Moats‐Staats, et al.. (2014). PTEN Deficiency Mediates a Reciprocal Response to IGFI and mTOR Inhibition. Molecular Cancer Research. 12(11). 1610–1620. 26 indexed citations
5.
Simon, Jeremy M., Michael D. Iglesia, Sam Wu, et al.. (2011). Tumor-specific retargeting of an oncogenic transcription factor chimera results in dysregulation of chromatin and transcription. Genome Research. 22(2). 259–270. 80 indexed citations
6.
Davis, Ian J., Andrew W. McFadden, Yixiang Zhang, et al.. (2010). Identification of the Receptor Tyrosine Kinase c-Met and Its Ligand, Hepatocyte Growth Factor, as Therapeutic Targets in Clear Cell Sarcoma. Cancer Research. 70(2). 639–645. 88 indexed citations
7.
Liu, Jun, Jan C. DeNofrio, Weiping Yuan, et al.. (2007). Genetic Manipulation of Megakaryocytes to Study Platelet Function. Current topics in developmental biology. 80. 311–335. 2 indexed citations
8.
Zayed, Mohamed A., Weiping Yuan, Thomas Leisner, et al.. (2007). CIB1 Regulates Endothelial Cells and Ischemia-Induced Pathological and Adaptive Angiogenesis. Circulation Research. 101(11). 1185–1193. 28 indexed citations
9.
Zhao, Bin, Thomas Leisner, Andrew W. McFadden, & Leslie V. Parise. (2007). Regulation of cell survival by CIB1, a new modulator of phosphoinositide‐dependent protein kinase‐1 (PDK1). The FASEB Journal. 21(6). 3 indexed citations
10.
Yuan, Weiping, Thomas Leisner, Andrew W. McFadden, et al.. (2006). CIB1 is an endogenous inhibitor of agonist-induced integrin αIIbβ3 activation. The Journal of Cell Biology. 172(2). 169–175. 65 indexed citations
11.
Zayed, Mohamed A., Andrew W. McFadden, Weiping Yuan, et al.. (2006). Critical Role of CIB1 in Endothelial Cell Function and In Vivo Ischemia-Induced Angiogenesis.. Blood. 108(11). 1800–1800.
12.
Yuan, Weiping, Andrew W. McFadden, Sylvia Hiller, et al.. (2006). CIB1 Is Essential for Mouse Spermatogenesis. Molecular and Cellular Biology. 26(22). 8507–8514. 58 indexed citations
13.
Shoman, Nael, et al.. (2004). Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen. Modern Pathology. 18(2). 250–259. 115 indexed citations
14.
McFadden, Andrew W., et al.. (2003). Synovial Chondromatosis and Chondrosarcoma: A Diagnostic Dilemma. Sarcoma. 7(2). 69–73. 35 indexed citations
15.
Barry, William T., David D. Shock, Andrew W. McFadden, et al.. (2002). Molecular Basis of CIB Binding to the Integrin αIIb Cytoplasmic Domain. Journal of Biological Chemistry. 277(32). 28877–28883. 51 indexed citations
16.
Radhi, Jasim, Leo F. Skinnider, & Andrew W. McFadden. (1997). Kikuchi's lymphadenitis and carcinoma of the stomach.. Journal of Clinical Pathology. 50(6). 530–531. 23 indexed citations
17.
Bear, Harry D., Andrew W. McFadden, Giselle G. Hamad, et al.. (1996). Bryostatin 1 activates splenic lymphocytes and induces sustained depletion of splenocyte protein kinase C activity in vivo after a single intravenous administration. Anti-Cancer Drugs. 7(3). 299–306. 6 indexed citations
18.
Fleming, Martin D., et al.. (1995). Adoptive Transfer of Bryostatin-Activated Tumor-Sensitized Lymphocytes Prevents or Destroys Tumor Metastases Without Expansion In Vitro. Journal of Immunotherapy. 18(3). 147–155. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vanessa Cerisano Breakdown of academic impact, for papers by Fumihiro Kimura Breakdown of academic impact, for papers by Ulla Aspenblad Breakdown of academic impact, for papers by Ana Teresa Amaral Breakdown of academic impact, for papers by Andreas Lux Breakdown of academic impact, for papers by Uwe Jerke Breakdown of academic impact, for papers by Abdo J. Najy Breakdown of academic impact, for papers by Carlos Rı́us Breakdown of academic impact, for papers by Veronica R. Placencio Breakdown of academic impact, for papers by Yingfu Liu
Rankless by CCL
2026